Because we designed our experimental mouse study to only measure the effects of PI3K p110γ mediated signaling in host cells, we were able to focus on how PI3K p110γ inhibition affects the host immune response to HNSCC. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.